Jeff Trauring News Today

Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc , a global leader in healthcare...

/PRNewswire/ -- A new survey commissioned by Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and conducted by public opinion research firm...

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective,...

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective,...

Medtronic Announces CareGuidePro, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey Medtronic plc the global leader in medical technology, today announced CareGuidePro™, a mobile application and web portal that serves as a virtual guide for patients throughout their Medtronic spinal cord stimulation therapy journey. The patient’s care team, including physicians and Medtronic, may also use the CareGuidePro platform to help manage and support ...

Medtronic Announces CareGuidePro™, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey New App Developed in Partnership with Higgs Boson Health, a Physician-Led Digital Health and Patient Engagement Solutions Provider News provided by Share this article Share this article DUBLIN, May 5, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CareGuidePro™, a mobile application and web portal tha...

Medtronic Receives Approval for U.S. Labeling of the Intellis Platform Showing Superior Back Pain Relief When Using DTM Spinal Cord Stimulation Medtronic plc the global leader in medical technology, today announced the U.S. Food and Drug Administration has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter ra...